Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) agreed to acquire 68% stake in Osmopharm SA for SAR 16.1 million on November 14, 2023. The transaction s expected to be completed in the first half of 2024, contingent on regulatory approvals. Olha Demianiuk and Dr. Alexander Wyss of Baker & McKenzie acted as legal advisor to Saudi Pharmaceutical Industries and Medical Appliances Corporation.
Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.45 SAR | +0.26% | +2.95% | +1.72% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.72% | 1.23B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 2070 Stock
- News Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million.